[Hormone therapy for breast cancer].
Saito
Yuki
Y
Department of Breast and Endocrine Surgery, Tokai University School of Medicine.
Suzuki
Yasuhiro
Y
Tokuda
Yutaka
Y
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D047072:Aromatase Inhibitors / Q000008:administration & dosage*; D001577:Benzophenones; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000502:physiology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D017273:Goserelin / Q000008:administration & dosage; D006801:Humans; D008593:Menopause / Q000502:physiology; D011960:Receptors, Estrogen / Q000502:physiology; D013629:Tamoxifen / Q000008:administration & dosage
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D001577:Benzophenones; D004967:Estrogens; D011960:Receptors, Estrogen; C437463:nemorosone; D013629:Tamoxifen; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone